These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22886382)

  • 1. Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population.
    Gono T; Kawaguchi Y; Kuwana M; Sugiura T; Furuya T; Takagi K; Ichida H; Katsumata Y; Hanaoka M; Ota Y; Yamanaka H
    Arthritis Rheum; 2012 Nov; 64(11):3736-40. PubMed ID: 22886382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    Chen Z; Wang Y; Kuwana M; Xu X; Hu W; Feng X; Wang H; Kimura A; Sun L
    J Rheumatol; 2017 Sep; 44(9):1389-1393. PubMed ID: 28711882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population.
    Lin JM; Zhang YB; Peng QL; Yang HB; Shi JL; Gu ML; Zhao WM; Wang GC
    HLA; 2017 Dec; 90(6):354-359. PubMed ID: 29106035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population.
    Gao X; Han L; Yuan L; Yang Y; Gou G; Sun H; Lu L; Bao L
    BMC Dermatol; 2014 Jun; 14():9. PubMed ID: 24894810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis.
    Chen Z; Hu W; Wang Y; Guo Z; Sun L; Kuwana M
    Clin Rheumatol; 2015 Sep; 34(9):1627-31. PubMed ID: 25903820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population.
    Chen S; Wang Q; Wu Z; Li Y; Li P; Sun F; Zheng W; Wu Q; Wu C; Deng C; Zhang F; Li Y
    PLoS One; 2014; 9(10):e110044. PubMed ID: 25337792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody.
    Cao H; Pan M; Kang Y; Xia Q; Li X; Zhao X; Shi R; Lou J; Zhou M; Kuwana M; Ding X; Zheng J
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1602-10. PubMed ID: 22623119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
    Hall JC; Casciola-Rosen L; Samedy LA; Werner J; Owoyemi K; Danoff SK; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1307-15. PubMed ID: 23436757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis.
    Gono T; Kawaguchi Y; Sugiura T; Furuya T; Kawamoto M; Hanaoka M; Yamanaka H
    Mod Rheumatol; 2010 Oct; 20(5):466-70. PubMed ID: 20467774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.
    Chen F; Wang D; Shu X; Nakashima R; Wang G
    Rheumatol Int; 2012 Dec; 32(12):3909-15. PubMed ID: 22198664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of anti-melanoma differentiation-associated gene 5 antibody in Hong Kong Chinese patients with idiopathic inflammatory myopathies: diagnostic utility and clinical correlations.
    So H; Ip RW; Wong VT; Yip RM
    Int J Rheum Dis; 2018 May; 21(5):1076-1081. PubMed ID: 29380533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
    Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.
    Nakashima R; Imura Y; Kobayashi S; Yukawa N; Yoshifuji H; Nojima T; Kawabata D; Ohmura K; Usui T; Fujii T; Okawa K; Mimori T
    Rheumatology (Oxford); 2010 Mar; 49(3):433-40. PubMed ID: 20015976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
    Kishaba T; McGill R; Nei Y; Ibuki S; Momose M; Nishiyama K; Nagano H; Yamashiro S
    J Med Invest; 2018; 65(3.4):251-257. PubMed ID: 30282869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission.
    Muro Y; Sugiura K; Hoshino K; Akiyama M
    Rheumatology (Oxford); 2012 May; 51(5):800-4. PubMed ID: 22210662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
    Ikeda S; Arita M; Morita M; Ikeo S; Ito A; Tokioka F; Noyama M; Misaki K; Notohara K; Ishida T
    BMC Pulm Med; 2015 Dec; 15():159. PubMed ID: 26651481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.